No-Hair Theorem for Spontaneously Broken Abelian Models in Static Black Holes

The vanishing of the electromagnetic field, for purely electric configurations of spontaneously broken Abelian models, is established in the domain of outer communications of a static asymptotically flat black hole. The proof is gauge invariant, and is accomplished without any dependence on the model. In the particular case of the Abelian Higgs model, it is shown that the only solutions admitted for the scalar field become the vacuum expectation values of the self-interaction.Comment: 8 pages, 2 figures, RevTeX; some changes to match published versio

On Black Hole Scalar Hair in Asymptotically Anti de Sitter Spacetimes

The unexpected discovery of hairy black hole solutions in theories with scalar fields simply by considering asymptotically Anti de-Sitter, rather than asymptotically flat, boundary conditions is analyzed in a way that exhibits in a clear manner the differences between the two situations. It is shown that the trivial Schwarzschild Anti de Sitter becomes unstable in some of these situations, and the possible relevance of this fact for the ADS/CFT conjecture is pointed out.Comment: 12 pages. Published versio

Algebraic approach to quantum black holes: logarithmic corrections to black hole entropy

The algebraic approach to black hole quantization requires the horizon area eigenvalues to be equally spaced. As shown previously, for a neutral non-rotating black hole, such eigenvalues must be $2^{n}$-fold degenerate if one constructs the black hole stationary states by means of a pair of creation operators subject to a specific algebra. We show that the algebra of these two building blocks exhibits $U(2)\equiv U(1)\times SU(2)$ symmetry, where the area operator generates the U(1) symmetry. The three generators of the SU(2) symmetry represent a {\it global} quantum number (hyperspin) of the black hole, and we show that this hyperspin must be zero. As a result, the degeneracy of the $n$-th area eigenvalue is reduced to $2^{n}/n^{3/2}$ for large $n$, and therefore, the logarithmic correction term $-3/2\log A$ should be added to the Bekenstein-Hawking entropy. We also provide a heuristic approach explaining this result, and an evidence for the existence of {\it two} building blocks.Comment: 15 pages, Revtex, to appear in Phys. Rev.

Scalar hairy black holes and solitons in asymptotically flat spacetimes

A numerical analysis shows that a class of scalar-tensor theories of gravity with a scalar field minimally and nonminimally coupled to the curvature allows static and spherically symmetric black hole solutions with scalar-field hair in asymptotically flat spacetimes. In the limit when the horizon radius of the black hole tends to zero, regular scalar solitons are found. The asymptotically flat solutions are obtained provided that the scalar potential $V(\phi)$ of the theory is not positive semidefinite and such that its local minimum is also a zero of the potential, the scalar field settling asymptotically at that minimum. The configurations for the minimal coupling case, although unstable under spherically symmetric linear perturbations, are regular and thus can serve as counterexamples to the no-scalar-hair conjecture. For the nonminimal coupling case, the stability will be analyzed in a forthcoming paper.Comment: 7 pages, 10 postscript figures, file tex, new postscript figs. and references added, stability analysis revisite

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors across 33 different cancer types. TCGA clinical data contain key features representing the democratized nature of the data collection process. To ensure proper use of this large clinical dataset associated with genomic features, we developed a standardized dataset named the TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR), which includes four major clinical outcome endpoints. In addition to detailing major challenges and statistical limitations encountered during the effort of integrating the acquired clinical data, we present a summary that includes endpoint usage recommendations for each cancer type. These TCGA-CDR findings appear to be consistent with cancer genomics studies independent of the TCGA effort and provide opportunities for investigating cancer biology using clinical correlates at an unprecedented scale. Analysis of clinicopathologic annotations for over 11,000 cancer patients in the TCGA program leads to the generation of TCGA Clinical Data Resource, which provides recommendations of clinical outcome endpoint usage for 33 cancer types

Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension

Importance: Complete information in a trial protocol regarding study outcomes is crucial for obtaining regulatory approvals, ensuring standardized trial conduct, reducing research waste, and providing transparency of methods to facilitate trial replication, critical appraisal, accurate reporting and interpretation of trial results, and knowledge synthesis. However, recommendations on what outcome-specific information should be included are diverse and inconsistent. To improve reporting practices promoting transparent and reproducible outcome selection, assessment, and analysis, a need for specific and harmonized guidance as to what outcome-specific information should be addressed in clinical trial protocols exists. Objective: To develop harmonized, evidence- and consensus-based standards for describing outcomes in clinical trial protocols through integration with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 statement. Evidence Review: Using the Enhancing the Quality and Transparency of Health Research (EQUATOR) methodological framework, the SPIRIT-Outcomes 2022 extension of the SPIRIT 2013 statement was developed by (1) generation and evaluation of candidate outcome reporting items via consultation with experts and a scoping review of existing guidance for reporting trial outcomes (published within the 10 years prior to March 19, 2018) identified through expert solicitation, electronic database searches of MEDLINE and the Cochrane Methodology Register, gray literature searches, and reference list searches; (2) a 3-round international Delphi voting process (November 2018-February 2019) completed by 124 panelists from 22 countries to rate and identify additional items; and (3) an in-person consensus meeting (April 9-10, 2019) attended by 25 panelists to identify essential items for outcome-specific reporting to be addressed in clinical trial protocols. Findings: The scoping review and consultation with experts identified 108 recommendations relevant to outcome-specific reporting to be addressed in trial protocols, the majority (72%) of which were not included in the SPIRIT 2013 statement. All recommendations were consolidated into 56 items for Delphi voting; after the Delphi survey process, 19 items met criteria for further evaluation at the consensus meeting and possible inclusion in the SPIRIT-Outcomes 2022 extension. The discussions during and after the consensus meeting yielded 9 items that elaborate on the SPIRIT 2013 statement checklist items and are related to completely defining and justifying the choice of primary, secondary, and other outcomes (SPIRIT 2013 statement checklist item 12) prospectively in the trial protocol, defining and justifying the target difference between treatment groups for the primary outcome used in the sample size calculations (SPIRIT 2013 statement checklist item 14), describing the responsiveness of the study instruments used to assess the outcome and providing details on the outcome assessors (SPIRIT 2013 statement checklist item 18a), and describing any planned methods to account for multiplicity relating to the analyses or interpretation of the results (SPIRIT 2013 statement checklist item 20a). Conclusions and Relevance: This SPIRIT-Outcomes 2022 extension of the SPIRIT 2013 statement provides 9 outcome-specific items that should be addressed in all trial protocols and may help increase trial utility, replicability, and transparency and may minimize the risk of selective nonreporting of trial results

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

Gene fusions represent an important class of somatic alterations in cancer. We systematically investigated fusions in 9,624 tumors across 33 cancer types using multiple fusion calling tools. We identified a total of 25,664 fusions, with a 63% validation rate. Integration of gene expression, copy number, and fusion annotation data revealed that fusions involving oncogenes tend to exhibit increased expression, whereas fusions involving tumor suppressors have the opposite effect. For fusions involving kinases, we found 1,275 with an intact kinase domain, the proportion of which varied significantly across cancer types. Our study suggests that fusions drive the development of 16.5% of cancer cases and function as the sole driver in more than 1% of them. Finally, we identified druggable fusions involving genes such as TMPRSS2, RET, FGFR3, ALK, and ESR1 in 6.0% of cases, and we predicted immunogenic peptides, suggesting that fusions may provide leads for targeted drug and immune therapy

Floristic composition and community structure of epiphytic angiosperms in a terra firme forest in central Amazonia

This survey aimed to describe the floristic composition and structure of the epiphytic community occurring in a terra firme forest in the city of Coari, Brazil, in the Amazon region. Data collection was performed with a 1.5 ha plot method, with which upland, slope and lowland habitats were sampled. All angiosperm epiphytes and their host plants (diameter at breast height > 10 cm) were sampled. We recorded 3.528 individuals in 13 families, 48 genera and 164 species. Araceae was the most prevalent family with regard to the importance value and stood out in all related parameters, followed by Bromeliaceae, Cyclanthaceae and Orchidaceae. The species with the highest epiphytic importance values were Guzmania lingulata (L.) Mez. and Philodendron linnaei Kunth. The predominant life form was hemiepiphytic. Estimated floristic diversity was 3.2 (H'). The studied epiphytic community was distributed among 727 host plants belonging to 40 families, 123 genera and 324 species. One individual of Guarea convergens T.D. Penn. was the host with the highest richness and abundance of epiphytes. Stems/trunks of host plants were the most colonized segments, and the most favorable habitat for epiphytism was the lowlands, where 84.1% of species and 48.2% of epiphytic specimens were observed